AIMS: To determine levels of microsomal protein (MPPGL) and hepatocellularity (HPGL) per gram of human liver and their interindividual variability. METHODS: Triplicate liver samples were used to determine values of MPPGL (n = 20) and HPGL (n = 7) after accounting for the fractional loss of microsomal protein or hepatocytes during processing. Repeated measurements from each liver sample allowed the estimation of true interindividual variability in MPPGL and HPGL using ANOVA. RESULTS: The value of MPPGL ranged from 26 to 54 mg g(-1) (mean(geo)= 33 mg g(-1)). The value of HPGL ranged from 65 to 185 x 10(6) cells g(-1) (mean(geo)= 10(7) x 10(6) cells g(-1)). CONCLUSIONS: There is significant interindividual variability in MPPGL, which has implications for the accurate extrapolation of in vitro data on drug metabolism to predict in vivo metabolic clearance.
AIMS: To determine levels of microsomal protein (MPPGL) and hepatocellularity (HPGL) per gram of human liver and their interindividual variability. METHODS: Triplicate liver samples were used to determine values of MPPGL (n = 20) and HPGL (n = 7) after accounting for the fractional loss of microsomal protein or hepatocytes during processing. Repeated measurements from each liver sample allowed the estimation of true interindividual variability in MPPGL and HPGL using ANOVA. RESULTS: The value of MPPGL ranged from 26 to 54 mg g(-1) (mean(geo)= 33 mg g(-1)). The value of HPGL ranged from 65 to 185 x 10(6) cells g(-1) (mean(geo)= 10(7) x 10(6) cells g(-1)). CONCLUSIONS: There is significant interindividual variability in MPPGL, which has implications for the accurate extrapolation of in vitro data on drug metabolism to predict in vivo metabolic clearance.
Authors: M J Paine; A P Garner; D Powell; J Sibbald; M Sales; N Pratt; T Smith; D G Tew; C R Wolf Journal: J Biol Chem Date: 2000-01-14 Impact factor: 5.157
Authors: G Powis; I Jardine; R Van Dyke; R Weinshilboum; D Moore; T Wilke; W Rhodes; R Nelson; L Benson; C Szumlanski Journal: Drug Metab Dispos Date: 1988 Jul-Aug Impact factor: 3.922
Authors: T Iwatsubo; H Suzuki; N Shimada; K Chiba; T Ishizaki; C E Green; C A Tyson; T Yokoi; T Kamataki; Y Sugiyama Journal: J Pharmacol Exp Ther Date: 1997-08 Impact factor: 4.030
Authors: John C Lipscomb; Linda K Teuschler; Jeffrey C Swartout; Cynthia A F Striley; John E Snawder Journal: Toxicol Mech Methods Date: 2003 Impact factor: 2.987
Authors: J P Ploemen; L W Wormhoudt; G R Haenen; M J Oudshoorn; J N Commandeur; N P Vermeulen; I de Waziers; P H Beaune; T Watabe; P J van Bladeren Journal: Toxicol Appl Pharmacol Date: 1997-03 Impact factor: 4.219
Authors: Sebastian Frechen; Lisa Junge; Teijo I Saari; Ahmed Abbas Suleiman; Dennis Rokitta; Pertti J Neuvonen; Klaus T Olkkola; Uwe Fuhr Journal: Clin Pharmacokinet Date: 2013-09 Impact factor: 6.447
Authors: John H Vernachio; Blair Bleiman; K Dawn Bryant; Stanley Chamberlain; Damound Hunley; Jeff Hutchins; Brenda Ames; Elena Gorovits; Babita Ganguly; Andrea Hall; Alexander Kolykhalov; Yule Liu; Jerry Muhammad; Nicholas Raja; C Robin Walters; Jin Wang; Karen Williams; Joseph M Patti; Geoffrey Henson; Karolina Madela; Mohamed Aljarah; Arnaud Gilles; Christopher McGuigan Journal: Antimicrob Agents Chemother Date: 2011-02-28 Impact factor: 5.191
Authors: Daniel G Miller; Grant D Trobridge; Lisa M Petek; Michael A Jacobs; Rajinder Kaul; David W Russell Journal: J Virol Date: 2005-09 Impact factor: 5.103